Landos Biopharma, Inc.

LABP · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$37,549$36,640$8,305$2,416
Short-Term Investments$0$7,762$82,575$25,718
Receivables$0$0$0$154
Inventory$0$0$0$1,398
Other Curr. Assets$491$851$1,266$202
Total Curr. Assets$38,040$45,253$92,146$29,888
Property Plant & Equip (Net)$0$0$707$444
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$26$0
Total NC Assets$0$0$733$444
Other Assets$0$0$0$0
Total Assets$38,040$45,253$92,879$30,332
Liabilities
Payables$1,375$3,435$12,908$8,606
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,874$2,687$3,703$2,428
Total Curr. Liab.$6,249$6,122$16,611$11,034
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$73,313
Total NC Liab.$0$3,435$0$73,313
Other Liabilities$0-$3,435$0$0
Cap. Leases$0$0$0$0
Total Liabilities$6,249$6,122$16,611$84,347
Equity
Pref Stock$0$0$92,879$73,037
Common Stock$31$403$403$71
Retained Earnings-$155,362-$133,427-$94,151-$55,729
AOCI$0-$57-$225$10
Other Equity$187,122$172,212$77,362-$71,404
Total Equity$31,791$39,131$76,268-$54,015
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$38,040$45,253$92,879$30,332
Net Debt-$37,549-$36,640-$8,305-$2,416